Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.
Recombinant human monoclonal antibody expressed in CHO binding to human PDCD1. Nivolumab is a fully human IgG4 monoclonal antibody for the treatment of cancer. Nivolumab acts as an immunomodulator by blocking ligand activation of the programmed cell death 1 (PD-1) receptor on activated T cells.
Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.